Janssen Pharmaceutica scholarships for biomedical start-ups
Janssen Pharmaceutica NV has made available 2 scholarships for the blended course Clinical Development from Paul Janssen Futurelab Leiden (PJ Futurelab). PJ Futurelab is a non-profit, independent education & training initiative of the Leiden University Medical Centre (LUMC) and Leiden University. Our mission is to train graduated biomedical professional to be tomorrow’s leaders in life sciences.
The scholarship awards the full course fee of €5600,- and gives access to the complete blended course Clinical Development: a 5-week online introduction course (study load 5 hours/week) + 4 days on-campus + 5 days on-campus extended. The international blended course Clinical Development from PJ Futurelab Leiden is highly rated by participants (4.4 out of 5 stars). Graduated biomedical professionals from promising start-ups are introduced to Question-Based Clinical Development and are guided on the development of a first-in-man trial. The course offers a unique opportunity to work on extensive teaching cases based on real R&D projects and to meet like-minded peers and key opinion leaders from prominent life sciences companies.
For more information, please find attached a short brochure and a letter signed by Marcel Kenter (Director PJ Futurelab) and Bart van Zijl Langhout (Janssen The Netherlands, Campus Lead).
Interested participants may apply for a scholarship directly through the website.
The application deadline for this scholarship is February 18, 2019, 12:00 CET.
The course starts on March 25, 2019.
For questions or sign up:
Mariella Franker, email@example.com